Sunesis Pharmaceuticals Inc. (SNSS) reported that its fourth-quarter net loss narrowed to $4.05 million from $8.74 million in the same quarter last year. However, on a per share basis, net loss widened to $0.20 from $0.19 last year. Total operating expenses increased to $10.06 million from $8.49 million in the year ago quarter.
Revenue for the latest-quarter was $1.99 million. However, the company did not generate revenue for the prior year quarter.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.